Global Fluid Biopsy Market - Segmented by Type, Technology, Indication, and Geography - Growth, Trends, and Forecast (2022 - 2030)
The global fluid biopsy market is expected to register a CAGR of 18% during 2018 to 2023 (the forecast period). Fluid biopsy, which is also known as liquid biopsy or fluid phase biopsy, is a procedure of sampling and analyzing non–solid biological tissues (blood and others), for the screening of cancer and other inflammatory conditions, associated with cardiac and other medical disorders.
Increase in the Number of Cancer Cases Being Reported Worldwide
Cancer prevalence data indicates the number of people diagnosed with cancer in their lifetime. Prevalence is determined by how often a cancer occurs, and by how long people normally live after diagnosis. The key facts stated by WHO estimate that cancer is the second leading cause of mortality across the globe, with around 14 million new cases and 8.2 million cancer-related deaths in 2012, and 8.8 million deaths in 2015. The number of new cases is expected to rise by about 70% in the next two decades. By 2030, the global burden is expected to grow to 21.7 million new cancer cases and 13 million cancer deaths, which can be attributed to the aging of the population. The future burden is expected to be even larger, because of the adoption of western lifestyles, such as smoking, poor diet, physical inactivity, and fewer childbirths, in economically developing countries. The demand for an early detection of the cancer is poised to influence the growth of the global market, in addition, rising demand of non-invasive procedures and lower cost with greater accuracy is expected to supplement the growth of this market.
Growth of Alternative Technologies like Optical Biopsies
Liquid biopsy, a technical revolution, has widely been used for the diagnosis of several common cancer types. However, the presence and development of alternative techniques might hamper the growth of the market. One such alternative technology that has been used in the recent times is the optical biopsy. It is a novel method that uses spectroscopy at selected wavelengths, to diagnose cancerous tumors or any pre-cancerous growths. Liquid biopsies mostly depend upon the tumor-derived cfDNA, for the identification of cancer. However, in some cases, these cfDNA have shown to account for less than 1% of the circulating DNA. In addition, normal genomic DNA is present in cfDNA that might create false positive results during the biopsy. As such, alternative methods with high sensitive techniques that can sequence even a small amount of mutant, tumor-derived cfDNA in context of high genomic DNA, is essential. With options, like optical biopsies and the effectiveness of tissue-derived biopsies, the growth of the liquid biopsy market may be hampered. The other factors, such as developing countries being keen on using traditional tissue-based biopsy techniques, are hindering market growth.
Asia-Pacific is Expected to Register a High CAGR
Asia-Pacific region has high market potential for the growth of the fluid biopsy market, due to high prevalence rate of cancer and increase in healthcare expenditure. This region is predicted to experience fast-paced growth, in terms of development and use of the fluid biopsy tests. North America has the highest market share and it is followed by the Europe.
Key Developments in the Market
• June 2017 - Grail doubled down on cancer liquid biopsy through merger with Cirina.
• January 2017 - Guardant Health created a new 500-plus-gene liquid biopsy panel with several leading pharmaceutical companies to accelerate clinical trials and drug development.
Major Players: QIAGEN, BIO-RAD LABORATORIES, CYNVENIO, DIAGNOLOGIX, EXOSOME SCIENCES, GUARDANT HEALTH, HORIZON DISCOVERY, ILLUMINA, and GRAIL, among others.
Reasons to Purchase this Report
• Current and future of fluid biopsy market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Increase in the Number of Cancer Cases Being Reported Worldwide
Cancer prevalence data indicates the number of people diagnosed with cancer in their lifetime. Prevalence is determined by how often a cancer occurs, and by how long people normally live after diagnosis. The key facts stated by WHO estimate that cancer is the second leading cause of mortality across the globe, with around 14 million new cases and 8.2 million cancer-related deaths in 2012, and 8.8 million deaths in 2015. The number of new cases is expected to rise by about 70% in the next two decades. By 2030, the global burden is expected to grow to 21.7 million new cancer cases and 13 million cancer deaths, which can be attributed to the aging of the population. The future burden is expected to be even larger, because of the adoption of western lifestyles, such as smoking, poor diet, physical inactivity, and fewer childbirths, in economically developing countries. The demand for an early detection of the cancer is poised to influence the growth of the global market, in addition, rising demand of non-invasive procedures and lower cost with greater accuracy is expected to supplement the growth of this market.
Growth of Alternative Technologies like Optical Biopsies
Liquid biopsy, a technical revolution, has widely been used for the diagnosis of several common cancer types. However, the presence and development of alternative techniques might hamper the growth of the market. One such alternative technology that has been used in the recent times is the optical biopsy. It is a novel method that uses spectroscopy at selected wavelengths, to diagnose cancerous tumors or any pre-cancerous growths. Liquid biopsies mostly depend upon the tumor-derived cfDNA, for the identification of cancer. However, in some cases, these cfDNA have shown to account for less than 1% of the circulating DNA. In addition, normal genomic DNA is present in cfDNA that might create false positive results during the biopsy. As such, alternative methods with high sensitive techniques that can sequence even a small amount of mutant, tumor-derived cfDNA in context of high genomic DNA, is essential. With options, like optical biopsies and the effectiveness of tissue-derived biopsies, the growth of the liquid biopsy market may be hampered. The other factors, such as developing countries being keen on using traditional tissue-based biopsy techniques, are hindering market growth.
Asia-Pacific is Expected to Register a High CAGR
Asia-Pacific region has high market potential for the growth of the fluid biopsy market, due to high prevalence rate of cancer and increase in healthcare expenditure. This region is predicted to experience fast-paced growth, in terms of development and use of the fluid biopsy tests. North America has the highest market share and it is followed by the Europe.
Key Developments in the Market
• June 2017 - Grail doubled down on cancer liquid biopsy through merger with Cirina.
• January 2017 - Guardant Health created a new 500-plus-gene liquid biopsy panel with several leading pharmaceutical companies to accelerate clinical trials and drug development.
Major Players: QIAGEN, BIO-RAD LABORATORIES, CYNVENIO, DIAGNOLOGIX, EXOSOME SCIENCES, GUARDANT HEALTH, HORIZON DISCOVERY, ILLUMINA, and GRAIL, among others.
Reasons to Purchase this Report
• Current and future of fluid biopsy market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
